202 related articles for article (PubMed ID: 6339044)
1. Prospective clinical trial of a human tumor cloning system.
Von Hoff DD; Clark GM; Stogdill BJ; Sarosdy MF; O'Brien MT; Casper JT; Mattox DE; Page CP; Cruz AB; Sandbach JF
Cancer Res; 1983 Apr; 43(4):1926-31. PubMed ID: 6339044
[TBL] [Abstract][Full Text] [Related]
2. [Update of human tumor clonogenic assay in carcinoma of the lung].
Kanzawa F
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395
[TBL] [Abstract][Full Text] [Related]
3. [In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].
Inoue K; Ogawa M; Mukaiyama T; Mitsui I; Inagaki J; Horikoshi N
Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):59-65. PubMed ID: 3889195
[No Abstract] [Full Text] [Related]
4. Selection of chemotherapy for patient treatment utilizing a radiometric versus a cloning system.
Von Hoff DD; Forseth BJ; Turner JN; Clark GM; Warfel LE
Int J Cell Cloning; 1986 Jan; 4(1):16-26. PubMed ID: 3950456
[TBL] [Abstract][Full Text] [Related]
5. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
6. Human tumor colony assay and chemosensitivity testing.
Salmon SE
Cancer Treat Rep; 1984 Jan; 68(1):117-25. PubMed ID: 6692423
[TBL] [Abstract][Full Text] [Related]
7. The human tumor stem cell assay revisited.
Singletary SE; Umbach GE; Spitzer G; Drewinko B; Tomasovic B; Ajani J; Hug V; Blumenschein G
Int J Cell Cloning; 1985 Mar; 3(2):116-28. PubMed ID: 3998518
[TBL] [Abstract][Full Text] [Related]
8. Application of a human tumor colony-forming assay to new drug screening.
Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
[TBL] [Abstract][Full Text] [Related]
9. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of drug resistance in human breast and ovarian cancers.
Kern DH
Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Alberts DS; Mackel C; Pocelinko R; Salmon SE
Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
[TBL] [Abstract][Full Text] [Related]
12. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
[TBL] [Abstract][Full Text] [Related]
13. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
Taetle R; Koessler AK; Howel SB
Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
[TBL] [Abstract][Full Text] [Related]
14. [Clinical correlations of drug sensitivity in the human tumor clonogenic assay--heterogeneity in drug sensitivity of human tumors].
Tanigawa N; Hikasa Y; Kern DH
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1152-7. PubMed ID: 6471422
[TBL] [Abstract][Full Text] [Related]
15. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
Cancer Treat Rep; 1981; 65(1-2):1-12. PubMed ID: 7226159
[TBL] [Abstract][Full Text] [Related]
16. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
18. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
19. Human tumor cloning: drug sensitivity testing clinical correlations.
Alberts DS; Salmon SE; Moon TE
Prog Clin Cancer; 1982; 8():147-79. PubMed ID: 6760247
[No Abstract] [Full Text] [Related]
20. Comparison of the human tumor cloning and subrenal capsule assays.
Bogden AE; Von Hoff DD
Cancer Res; 1984 Mar; 44(3):1087-90. PubMed ID: 6692394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
